Prince William County Community Services Board - Medicare Mental Health Clinic in Manassas, VA

Prince William County Community Services Board is a medicare enrolled mental health clinic (Clinic/center - Mental Health (including Community Mental Health Center)) in Manassas, Virginia. The current practice location for Prince William County Community Services Board is 7969 Ashton Ave, Manassas, Virginia. For appointments, you can reach them via phone at (703) 792-7800. The mailing address for Prince William County Community Services Board is 7969 Ashton Ave, Manassas, Virginia and phone number is (703) 792-7800.

Prince William County Community Services Board is licensed to practice in * (Not Available) (license number ). The clinic also participates in the medicare program and its NPI number is 1053402800. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (703) 792-7800.

Contact Information

Prince William County Community Services Board
7969 Ashton Ave
Manassas
VA 20109-2885
(703) 792-7800
(703) 792-5699

Mental Health Clinic Profile

Full NamePrince William County Community Services Board
SpecialityClinic/Center
Location7969 Ashton Ave, Manassas, Virginia
Authorized Official Name and PositionAnsar Shand (MANAGER)
Authorized Official Contact7037927800
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Prince William County Community Services Board
7969 Ashton Ave
Manassas
VA 20109-2885

Ph: (703) 792-7800
Prince William County Community Services Board
7969 Ashton Ave
Manassas
VA 20109-2885

Ph: (703) 792-7800

NPI Details:

NPI Number1053402800
Provider Enumeration Date09/27/2006
Last Update Date10/30/2013

Medicare PECOS Information:

Medicare PECOS PAC ID7113912973
Medicare Enrollment IDO20040420000249

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Medical Identifiers

Medical identifiers for Prince William County Community Services Board such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1053402800NPI-NPPES
004978277MedicaidVA
210245OtherVABLUE CROSS BLUE SHIELD
004945247MedicaidVA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
261QM0801XClinic/center - Mental Health (including Community Mental Health Center) (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Prince William County Community Services Board acts as a billing entity for following providers:
Provider NameJill A Parker
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1720119886
PECOS PAC ID: 7113912411
Enrollment ID: I20040416000647

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameAudrey M Rushin
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1689727349
PECOS PAC ID: 2062490675
Enrollment ID: I20040710000028

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameSwarna Reddy
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1528044583
PECOS PAC ID: 5496711830
Enrollment ID: I20041207000751

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameRuby Thomas
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1497705032
PECOS PAC ID: 8628012986
Enrollment ID: I20050616001121

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameEvelyn M Hatfield
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1023124526
PECOS PAC ID: 4082716410
Enrollment ID: I20070302000372

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameImran Akram
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1053449389
PECOS PAC ID: 9234237124
Enrollment ID: I20070530000378

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameSumera Nadeem
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1225226152
PECOS PAC ID: 6406922590
Enrollment ID: I20080915000398

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameJyoti H Supanekar
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1902943483
PECOS PAC ID: 0244262251
Enrollment ID: I20090317000418

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameKatharine H Mchugh
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1841424637
PECOS PAC ID: 4981757655
Enrollment ID: I20090728000301

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameLaura L Harvatine
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1669407573
PECOS PAC ID: 3375546757
Enrollment ID: I20110517000798

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameClaudia L Bailey
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1235216771
PECOS PAC ID: 3577726694
Enrollment ID: I20120529000369

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameNina Khachiyants
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1376706887
PECOS PAC ID: 5395993760
Enrollment ID: I20120911000210

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameNanah Sesay
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1306171145
PECOS PAC ID: 9830348630
Enrollment ID: I20121011000818

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameMohammad A Ansari
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1891874863
PECOS PAC ID: 3274567300
Enrollment ID: I20121205000513

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameSyed W Rizvi
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1396824363
PECOS PAC ID: 9931151784
Enrollment ID: I20130102000263

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameRajeev Sharma
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1710309950
PECOS PAC ID: 9335367960
Enrollment ID: I20140824000007

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameMerrielyn J Maldonado
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1114156601
PECOS PAC ID: 3779704853
Enrollment ID: I20141015001611

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameRichard Rosse
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1316049570
PECOS PAC ID: 6800196965
Enrollment ID: I20151123001530

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameLenelle M Mozell
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1841414703
PECOS PAC ID: 2264735869
Enrollment ID: I20160114000801

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameLedro Justice
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1306948526
PECOS PAC ID: 3779477526
Enrollment ID: I20160212001609

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameGagandeep Khurana
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1104261858
PECOS PAC ID: 7517275233
Enrollment ID: I20160413000129

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameKanchan P Clark
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1649230509
PECOS PAC ID: 0941590608
Enrollment ID: I20161017002292

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameDonovan D Clark
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1235199100
PECOS PAC ID: 9234429457
Enrollment ID: I20161019003190

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameSirajul Hasan
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1144561499
PECOS PAC ID: 5597053504
Enrollment ID: I20170316001838

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameStacey Burton
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1265680557
PECOS PAC ID: 7719166644
Enrollment ID: I20170329001543

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameRajinderpal Singh
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1548420813
PECOS PAC ID: 0547547838
Enrollment ID: I20170516001630

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameJacquelyn Marie Brannock
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1063942670
PECOS PAC ID: 3274809157
Enrollment ID: I20171019003142

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameTracie B Rivera
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1477787026
PECOS PAC ID: 3870747132
Enrollment ID: I20171211000246

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameCaitlyn Bills
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1528550159
PECOS PAC ID: 4486902558
Enrollment ID: I20180806002594

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameLaurence S Shindelman
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1073634960
PECOS PAC ID: 3375892961
Enrollment ID: I20180815000477

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameKossi Pierre Eklou
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1609360635
PECOS PAC ID: 9335490432
Enrollment ID: I20181001000276

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameChristabel Lartey
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1962762237
PECOS PAC ID: 4688928484
Enrollment ID: I20181206003255

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameSarah Ann Burns
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1538640677
PECOS PAC ID: 7618216979
Enrollment ID: I20190304001490

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameAllison Marquardt
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1326505082
PECOS PAC ID: 6406199819
Enrollment ID: I20190528000257

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameKarie Lyn Johnson
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1376800573
PECOS PAC ID: 8820242290
Enrollment ID: I20200303001244

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameSarah Elizabeth Lee Hickey
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1326587809
PECOS PAC ID: 8729416896
Enrollment ID: I20200324001453

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameDiminga Ester Duke-pratt
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1134741614
PECOS PAC ID: 3476974007
Enrollment ID: I20200605001625

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameEdward Carl Huycke
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1215904826
PECOS PAC ID: 4880016732
Enrollment ID: I20200622002715

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameKhalida Jahed
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1801494489
PECOS PAC ID: 2466862339
Enrollment ID: I20201104000362

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameMalinda Ann Abramovich
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1962051912
PECOS PAC ID: 3072923473
Enrollment ID: I20201112002332

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameTrisha Nicole Ungar
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1255841078
PECOS PAC ID: 8729499314
Enrollment ID: I20201203001689

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameKatherine Suzanne Hetrick
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1245833466
PECOS PAC ID: 4688086507
Enrollment ID: I20201218000267

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameShariff T Ruffin
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1487242855
PECOS PAC ID: 6800201161
Enrollment ID: I20210218000945

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameAida Bengussie
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1982299889
PECOS PAC ID: 5890103501
Enrollment ID: I20210419001854

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameSarah Ann Duffy
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1124636162
PECOS PAC ID: 1557779006
Enrollment ID: I20210421001727

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameTammy Denise Knoll
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1578144291
PECOS PAC ID: 2264840404
Enrollment ID: I20210428000364

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameSaroj Uprety
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1558943100
PECOS PAC ID: 6103235197
Enrollment ID: I20210504000270

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameDaniel Matthew Manza
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1255855078
PECOS PAC ID: 6800205147
Enrollment ID: I20210517002195

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameKathryn Marie Bowler
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1821698192
PECOS PAC ID: 3476962739
Enrollment ID: I20210518000087

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameKathryn Thorn Weaver
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1992330906
PECOS PAC ID: 5991105405
Enrollment ID: I20210621000369

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameDominique Danquah
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1164005617
PECOS PAC ID: 5799188611
Enrollment ID: I20210729000424

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameMinh-chau Nguyen
Provider TypePractitioner - Psychiatry
Provider IdentifiersNPI Number: 1851321491
PECOS PAC ID: 5496774390
Enrollment ID: I20210914002869

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameKym M Ludwig
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1215694807
PECOS PAC ID: 6507251212
Enrollment ID: I20220316001179

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NamePatty Jane Zavaleta
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1821742347
PECOS PAC ID: 7214322692
Enrollment ID: I20220322000853

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameKendra M Griffin
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1669198321
PECOS PAC ID: 5799154803
Enrollment ID: I20221213000971

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameHarry Hogshead
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1508570896
PECOS PAC ID: 0941671267
Enrollment ID: I20230125000967

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameYasmeen Atyia Ayesha Burnell
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1205543410
PECOS PAC ID: 4082085089
Enrollment ID: I20230131001602

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameIsabel Patricia Navarro
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1912603770
PECOS PAC ID: 7012380389
Enrollment ID: I20230307002439

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameRenita Livingston
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1801294533
PECOS PAC ID: 8820463078
Enrollment ID: I20230331001608

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameAngel Bartlett
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1801409123
PECOS PAC ID: 3274908330
Enrollment ID: I20230404001244

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameVeronica Newman
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1780379883
PECOS PAC ID: 0143685941
Enrollment ID: I20230501001885

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameTomasina Rucker
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1073399176
PECOS PAC ID: 3678920782
Enrollment ID: I20231111000096

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameSamuel Woldeghebriel Seium
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1346863214
PECOS PAC ID: 0244680668
Enrollment ID: I20231228000148

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameSarah Jane Clarius
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1518528884
PECOS PAC ID: 0941650238
Enrollment ID: I20231228003035

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameJessica Lorita Thomas
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1629424353
PECOS PAC ID: 9931559093
Enrollment ID: I20240102002042

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameVester Appiah
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1508544933
PECOS PAC ID: 3577913649
Enrollment ID: I20240102002454

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameKatherine Valliere
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1699030908
PECOS PAC ID: 3577913599
Enrollment ID: I20240103000579

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NamePaula V Arce
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1093481186
PECOS PAC ID: 1951752948
Enrollment ID: I20240103003416

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameOlivia Adelle Sweetnam
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1770105744
PECOS PAC ID: 4688025687
Enrollment ID: I20240103003773

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameSharon Elizabeth Perrine
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1417666934
PECOS PAC ID: 8729439732
Enrollment ID: I20240103003959

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameChristopher Harold Smith
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1831273564
PECOS PAC ID: 5890146757
Enrollment ID: I20240105000159

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameJacqueline Olivia Campa
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1710631213
PECOS PAC ID: 3375994098
Enrollment ID: I20240108000652

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameNichole Dixon Wray
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1932734993
PECOS PAC ID: 1557712056
Enrollment ID: I20240109003503

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameTalifa Yvonne Bailey
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1568978310
PECOS PAC ID: 6608227962
Enrollment ID: I20240111000088

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameErka Mucaj
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1003346941
PECOS PAC ID: 3476904616
Enrollment ID: I20240111003236

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameAnn Calvert Brown
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1326125832
PECOS PAC ID: 3678924818
Enrollment ID: I20240111003479

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameAmanda Marie Ward
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1346948767
PECOS PAC ID: 4789036732
Enrollment ID: I20240116001820

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameM.claire H Dutrow
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1265516595
PECOS PAC ID: 6608228127
Enrollment ID: I20240122000017

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameNicole Lee Ann Brooks
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1639889280
PECOS PAC ID: 4486006855
Enrollment ID: I20240122002080

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameMarla Anne Peterson
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1821527102
PECOS PAC ID: 2466895610
Enrollment ID: I20240205003906

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameBrittany Rouiller
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1730966813
PECOS PAC ID: 3173966579
Enrollment ID: I20240212004483

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameArthur Daniel Square
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1255983987
PECOS PAC ID: 5294179248
Enrollment ID: I20240216004009

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameKatherine Grace Briggs
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1639263817
PECOS PAC ID: 8022452960
Enrollment ID: I20240219001871

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameNadia Marie Asfahani
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1922185453
PECOS PAC ID: 5294179115
Enrollment ID: I20240220000988

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameEmily N Girard
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1639559875
PECOS PAC ID: 2163866732
Enrollment ID: I20240222001449

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameSuzanne Brooks Herberg
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1497839732
PECOS PAC ID: 7214371806
Enrollment ID: I20240222002005

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameBrittany Lynn Anderson
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1902559974
PECOS PAC ID: 4385088822
Enrollment ID: I20240222003835

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

Provider NameDonna Armstrong
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1417404807
PECOS PAC ID: 4385089424
Enrollment ID: I20240229000055

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more Medical News

› Verified 7 days ago

News Archive

Could GRP78 be a therapeutic target against COVID-19?

A new study by a team of researchers at the Keck School of Medicine, University of Southern California, USA, reports a potentially important therapeutic target in the form of a molecule called GRP78 that promotes the entry and protein production by many viruses. The team's paper has been published in the Journal of Biological Chemistry.

Amid health bill delays and snags, lawmakers target issues

The wait for the Congressional Budget Office score on the Senate health care reform bill has left Senators with time to carefully consider all the angles on reform, The New York Times reports. Senate Majority Leader Harry Reid "has already received some substantial analysis of his measure, and if the numbers had been what he wanted, he would have released a bill by now.

FDA issues Complete Response letter to MAP's NDA for LEVADEX

MAP Pharmaceuticals, Inc. today announced that the United States Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for LEVADEX (dihydroergotamine) inhalation aerosol.

Researchers develop new way to analyze mucus binding

The human body is full of mucus. This viscous goo isn't just a nuisance that gets coughed up or sneezed out - it can bind to drugs, toxins or microbes, potentially impacting human health. However, relatively little is known about such interactions.

Read more News

› Verified 7 days ago

Clinic/Center in Manassas, VA

New Leaf Counseling, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 8712 Sudley Rd, Manassas, VA 20110
Phone: 571-599-0312    
Counseling Bliss
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 9246b Mosby St, Manassas, VA 20110
Phone: 571-358-1728    
Talako Industries
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 8711 Plantation Ln Ste 301, Manassas, VA 20110
Phone: 703-345-0588    
Gpc Therapy Associates, Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 9300 Forest Point Cir, Manassas, VA 20110
Phone: 703-508-4578    
Gateway Integrative Therapy Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 9720 Capital Ct Ste 100, Manassas, VA 20110
Phone: 703-895-6466    
Northern Virginia Christian Counseling
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 10620 Crestwood Dr, Manassas, VA 20109
Phone: 814-474-6454    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.